Sanger Sequencing Diagnostic Services Market Research Report – Segmentation By Type (Instruments, Reagents, and Software & Services); By End User (Academic and Research Institutes, Hospitals and Clinics, and Pharmaceutical and Biotechnology Companies); By Technology (Sanger Sequencing, and Next-Generation Sequencing); and Region; - Size, Share, Growth Analysis | Forecast (2024– 2030)
Published: 2024 - January
Report Code: IM-16208
Format:
Region: Global
Chapter 1. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– SCOPE & METHODOLOGY
1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET – EXECUTIVE SUMMARY
2.1. Market Size & Forecast – (2024 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.4. Attractive Investment Propositions
2.5. COVID-19 Impact Analysis
Chapter 3. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– COMPETITION SCENARIO
3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis
Chapter 4. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET - ENTRY SCENARIO
4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.5. PESTLE Analysis
4.4. Porters Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET- LANDSCAPE
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– BY TYPE
6.1. Introduction/Key Findings
6.2. Drip Irrigation
6.3. Micro Sprinkler Irrigation
6.4. Boom Irrigation
6.5. Capillary Irrigation
6.6. Y-O-Y Growth trend Analysis By Type
6.7. Absolute $ Opportunity Analysis By Type , 2024-2030
Chapter 7. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– BY TECHNOLOGY
7.1. Introduction/Key Findings
7.2. Sanger Sequencing
7.3. Next-Generation Sequencing
7.4. Y-O-Y Growth trend Analysis By TECHNOLOGY
7.5. Absolute $ Opportunity Analysis By TECHNOLOGY , 2024-2030
Chapter 8. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– BY End User
8.1. Introduction/Key Findings
8.2. Academic and Research Institutes
8.3. Hospitals and Clinics
8.4. Pharmaceutical and Biotechnology Companies
8.5. Y-O-Y Growth trend Analysis End User
8.6. Absolute $ Opportunity Analysis End User , 2024-2030
Chapter 9. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET, BY GEOGRAPHY – MARKET SIZE, FORECAST, TRENDS & INSIGHTS
9.1. North America
9.1.1. By Country
9.1.1.1. U.S.A.
9.1.1.2. Canada
9.1.1.3. Mexico
9.1.2. By TECHNOLOGY
9.1.3. By Type
9.1.4. By End User
9.1.5. Countries & Segments - Market Attractiveness Analysis
9.2. Europe
9.2.1. By Country
9.2.1.1. U.K.
9.2.1.2. Germany
9.2.1.3. France
9.2.1.4. Italy
9.2.1.5. Spain
9.2.1.6. Rest of Europe
9.2.2. By TECHNOLOGY
9.2.3. By End User
9.2.4. By Type
9.2.5. Countries & Segments - Market Attractiveness Analysis
9.3. Asia Pacific
9.3.2. By Country
9.3.2.2. China
9.3.2.2. Japan
9.3.2.3. South Korea
9.3.2.4. India
9.3.2.5. Australia & New Zealand
9.3.2.6. Rest of Asia-Pacific
9.3.2. By TECHNOLOGY
9.3.3. By Type
9.3.4. By End User
9.3.5. Countries & Segments - Market Attractiveness Analysis
9.4. South America
9.4.3. By Country
9.4.3.3. Brazil
9.4.3.2. Argentina
9.4.3.3. Colombia
9.4.3.4. Chile
9.4.3.5. Rest of South America
9.4.2. By TECHNOLOGY
9.4.3. By Type
9.4.4. By End User
9.4.5. Countries & Segments - Market Attractiveness Analysis
9.5. Middle East & Africa
9.5.4. By Country
9.5.4.4. United Arab Emirates (UAE)
9.5.4.2. Saudi Arabia
9.5.4.3. Qatar
9.5.4.4. Israel
9.5.4.5. South Africa
9.5.4.6. Nigeria
9.5.4.7. Kenya
9.5.4.8. Egypt
9.5.4.9. Rest of MEA
9.5.2. By TECHNOLOGY
9.5.3. By Type
9.5.4. By End User
9.5.5. Countries & Segments - Market Attractiveness Analysis
Chapter 10. GLOBAL SANGER SEQUENCING DIAGNOSTIC SERVICES MARKET– COMPANY PROFILES – (OVERVIEW, PRODUCT PORTFOLIO, FINANCIALS, STRATEGIES & DEVELOPMENTS)
10.1 Thermo Fisher Scientific Inc (U.S.)
10.2. Source BioScience (U.K.)
10.3. GenScript (U.S.)
10.4. LGC Limited (U.K.)
10.5. CeMIA (U.S.),
10.6. Quintara Biosciences (U.S.)
10.7. GenHunter Corporation (U.S.)
10.8. GENEWIZ (U.S.), Nucleics (U.K.)
10.9. SciGenom Labs Pvt. Ltd (India)
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
The Sanger Sequencing Diagnostic Services Market was valued at USD 1.92 billion in 2023 and is projected to reach a market size of USD 6.3 billion by the end of 2030. Over the forecast period of 2024-2030, the market is estimated to grow at a CAGR of 18.5%.
The market for Sanger's sequencing services is expanding due to technological developments in sequencing methods and its diagnostic services.
Sanger Sequencing Diagnostic Services Market is segmented based on type, technology, end user, and Region.
North America is the most dominant region for the Sanger Sequencing Diagnostic Services Market.
. Thermo Fisher Scientific Inc, Source BioScience, and GenScript are the few of the key players operating in the Sanger Sequencing Diagnostic Services Market.
